Andrew Stolz
- Pharmacology top 0.05%
- Drug-Induced Hepatotoxicity and Protection 37
- Pharmacogenetics and Drug Metabolism 26
- Hepatology top 2%
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 29
- Cell Biology top 2%
- Aldose Reductase and Taurine 20
-
- Liver Disease Diagnosis and Treatment 23
-
- Alcohol Consumption and Health Effects 9
-
- Hormonal Regulation and Hypertension 7
-
- Poisoning and overdose treatments 7
- Co-authors
- Robert J. FontanaNeil KaplowitzHuiman X. BarnhartHajime TakikawaPaul H. HayashiK. Rajender ReddyJosé SerranoDavid E. Kleiner
- Cited by
- PharmacologyHepatologyOncology
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Andrew Stolz
90 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Pharmacology 1.6k
- Hepatology 516
- Oncology 986
- Cell Biology 554
- Pediatrics, Perinatology and Child Health 486
Countries citing papers authored by Andrew Stolz
This map shows the geographic impact of Andrew Stolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Stolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Stolz more than expected).
Fields of papers citing papers by Andrew Stolz
This network shows the impact of papers produced by Andrew Stolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Stolz. The network helps show where Andrew Stolz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Stolz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 25 | |
| 6 | 2022 | 6 | |
| 7 | 2021 | 21 | |
| 8 | 2019 | 36 | |
| 9 | 2015 | 67 | |
| 10 | 2015 | 7 | |
| 11 | Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Networkbreakdown → | 2014 | 292 |
| 12 | 2014 | 94 | |
| 13 | 2007 | 52 | |
| 14 | Increasing AKR1C1 and AKR1C2 dependent DHT catabolism in prostate cancer (CaP) cell lines by Phase II Inducers can prevent DHT-dependent gene expression: implications for chemoprevention of CaP | 2006 | 0 |
| 15 | 2006 | 86 | |
| 16 | 2003 | 21 | |
| 17 | 2003 | 72 | |
| 18 | 1999 | 59 | |
| 19 | 1996 | 214 | |
| 20 | 1990 | 24 |
About Andrew Stolz
Andrew Stolz is a scholar working on Pharmacology, Hepatology and Cell Biology, having authored 97 papers that have together received 3.6k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (37 papers), Drug Transport and Resistance Mechanisms (29 papers), Pharmacogenetics and Drug Metabolism (26 papers), Liver Disease Diagnosis and Treatment (23 papers), Aldose Reductase and Taurine (20 papers), Alcohol Consumption and Health Effects (9 papers), Hormonal Regulation and Hypertension (7 papers) and Poisoning and overdose treatments (7 papers). The work is most often cited by research in Pharmacology (1.6k citations), Hepatology (516 citations) and Oncology (986 citations). Andrew Stolz has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Robert J. Fontana, Neil Kaplowitz, Huiman X. Barnhart, Hajime Takikawa, Paul H. Hayashi, K. Rajender Reddy, José Serrano, David E. Kleiner, Victor J. Navarro and Jay H. Hoofnagle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.